Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration

Background. Most patients with metastatic prostate cancer are endocrinologically treated with LHRH agonist, but finally castration-refractory and hormone-refractory cancers occur. Serum testosterone levels get low to “the castration level” by LHRH agonists but may not get low enough against castrati...

Full description

Saved in:
Bibliographic Details
Main Authors: Zaitsu, Masayoshi, Yamanoi, Mariko, Mikami, Koji, Takeshima, Yuta, Okamoto, Naohiko, Imao, Sadao, Tonooka, Akiko, Takeuchi, Takumi
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2012
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3130489/
https://ncbi.nlm.nih.gov/pubmed/21754927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/979154
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items